Literature DB >> 14718022

Down-regulation of members of glycolipid-enriched membrane raft gene family, MAL and BENE, in cervical squamous cell cancers.

Mitsuko Hatta1, Hisaki Nagai, Keiko Okino, Masamitsu Onda, Koichi Yoneyama, Yujirou Ohta, Hiroki Nakayama, Tsutomu Araki, Mitsuru Emi.   

Abstract

Persistent human papillomavirus infections cause infected epithelial cells to lose cellular polarity leading to cell transformation. Glycolipid-enriched membrane (GEM) rafts are implicated in polarized sorting of apical membrane proteins in epithelial cells and even in signal transduction. The MAL and BENE are essential component of the GEM raft's machinery for apical sorting of membrane proteins. In this study we demonstrated down-regulation of MAL and BENE mRNA in over two-thirds of primary cervical squamous cell cancers (14 and 15 of 20 cases, for MAL and BENE, respectively) when compared to corresponding non-cancerous uterine squamous cells. Allelic loss or hyper-methylation was not accompanied by MAL or BENE mRNA down-expression in human primary cervical cancers in microsatellite allelic analysis and HpaII-PCR-based methylation analysis of the MAL and BENE genomic region. In addition, we note down-regulation of these genes in established cervical cancer cell lines. These results suggest that down-regulation of MAL and BENE genes, which are essential components of the cellular polarized sorting system, play an important role in human cervical squamous cell cancer development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14718022     DOI: 10.1111/j.1341-8076.2004.00156.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  16 in total

1.  CMTM3 is frequently reduced in clear cell renal cell carcinoma and exhibits tumor suppressor activities.

Authors:  J Xie; Y Yuan; Z Liu; Y Xiao; X Zhang; C Qin; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2013-08-02       Impact factor: 3.405

2.  CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo.

Authors:  Y Xiao; Y Yuan; Y Zhang; J Li; Z Liu; X Zhang; Z Sheng; T Xu; X Wang
Journal:  Clin Transl Oncol       Date:  2014-11-12       Impact factor: 3.405

3.  Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.

Authors:  Saskia M Wilting; Jillian de Wilde; Chris J L M Meijer; Johannes Berkhof; Yajun Yi; Wessel N van Wieringen; Boudewijn J M Braakhuis; Gerrit A Meijer; Bauke Ylstra; Peter J F Snijders; Renske D M Steenbergen
Journal:  Genes Chromosomes Cancer       Date:  2008-10       Impact factor: 5.006

4.  Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.

Authors:  Hisani N Horne; Paula S Lee; Susan K Murphy; Miguel A Alonso; John A Olson; Jeffrey R Marks
Journal:  Mol Cancer Res       Date:  2009-02-10       Impact factor: 5.852

Review 5.  The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer.

Authors:  Armando Rubio-Ramos; Leticia Labat-de-Hoz; Isabel Correas; Miguel A Alonso
Journal:  Cells       Date:  2021-04-30       Impact factor: 6.600

6.  Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.

Authors:  Wei Cao; Zhi-Yuan Zhang; Qin Xu; Qiang Sun; Ming Yan; Jun Zhang; Ping Zhang; Ze-Guang Han; Wan-Tao Chen
Journal:  Mol Cancer       Date:  2010-11-22       Impact factor: 27.401

7.  Function of membrane rafts in viral lifecycles and host cellular response.

Authors:  Tadanobu Takahashi; Takashi Suzuki
Journal:  Biochem Res Int       Date:  2011-12-07

8.  Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.

Authors:  Guro E Lind; Terje Ahlquist; Matthias Kolberg; Marianne Berg; Mette Eknaes; Miguel A Alonso; Anne Kallioniemi; Gunn I Meling; Rolf I Skotheim; Torleiv O Rognum; Espen Thiis-Evensen; Ragnhild A Lothe
Journal:  J Transl Med       Date:  2008-03-17       Impact factor: 5.531

9.  Candidate metastasis suppressor genes uncovered by array comparative genomic hybridization in a mouse allograft model of prostate cancer.

Authors:  Yajun Yi; Srinivas Nandana; Thomas Case; Colleen Nelson; Tatjana Radmilovic; Robert J Matusik; Karen D Tsuchiya
Journal:  Mol Cytogenet       Date:  2009-09-26       Impact factor: 2.009

10.  Methylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16.

Authors:  Eun Young Ki; Keun Ho Lee; Soo Young Hur; Jee Eun Rhee; Mee Kyung Kee; Chung Kang; Jong Sup Park
Journal:  Int J Gynecol Cancer       Date:  2016-01       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.